As we move into 2018 there are a number of trends we can expect to drive activity in the pharmaceutical industry over the coming months. In this article with European Pharmaceutical Manufacturer, Mark Quick, Executive Vice President of Corporate Development discusses what we can expect from 2018 as part of a roundtable with industry experts.
Pharmaceutical companies are facing a lot of pressure to reduce the costs of medicines for the end user and they’re looking for ways to reduce both costs and time to market by improving efficiencies throughout the supply chain.
From an increased focus on driving efficiencies in the supply chain and the introduction of automation technologies, to serialisation and continued consolidation, Mark talks about the impact these trends will have on the outsourcing space and the wider pharmaceutical industry and the adjustments companies need to make in order to stay ahead of the curve.
Read the full article here: Pharma’s Fantastic Four — what to watch out for over the coming 12 months in pharma